The Korean Journal of Parasitology (KJP)

Nanoparticles as a Delivery System of Antigens for the Development of an Effective Vaccine against Toxoplasma gondii

Carina Brito, Camila Lourenço, Joana Magalhães, Salette Reis, Margarida Borges

Metallic Nanoparticles and Core-Shell Nanosystems in the Treatment, Diagnosis, and Prevention of Parasitic Diseases

Grzegorz Król, Kamila Fortunka, Michał Majchrzak, Ewelina Piktel, Paulina Paprocka, Angelika Mańkowska, Agata Lesiak, Maciej Karasiński, Agnieszka Strzelecka, Bonita Durnaś, Robert Bucki

Toxoplasmosis: stages of the protozoan life cycle and risk assessment in humans and animals for an enhanced awareness and an improved socio-economic status

Saudi Journal of Biological Sciences.2021; 28(1): 962. CrossRef

Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection

Nadia Arcon, Mariano S. Picchio, Ignacio M. Fenoy, Rosalía E. Moretta, Ariadna S. Soto, Matías D. Perrone Sibilia, Vanesa R. Sánchez, Cecilia A. Prato, María Virginia Tribulatti, Alejandra Goldman, Valentina Martin

Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host

Delphine Le Roux, Vitomir Djokic, Solen Morisse, Clément Chauvin, Vanessa Doré, Anne-Claire Lagrée, Déborah Voisin, Yohan Villain, Aurélie Grasset-Chevillot, Fanny Boursin, Chunlei Su, Sébastien Perrot, Isabelle Vallée, Edouard Seche, Radu Blaga

A Review on the Prevalence of Toxoplasma gondii in Humans and Animals Reported in Malaysia from 2008–2018

Mohammed Nasiru Wana, Mohamad Aris Mohd Moklas, Malaika Watanabe, Norshariza Nordin, Ngah Zasmy Unyah, Sharif Alhassan Abdullahi, Ashraf Ahmad Issa Alapid, Tijjani Mustapha, Rusliza Basir, Roslaini Abd. Majid

International Journal of Environmental Research and Public Health.2020; 17(13): 4809. CrossRef

In Silico Prediction of T and B Cell Epitopes of SAG1-Related Sequence 3 (SRS3) Gene for Developing Toxoplasma gondii Vaccine

Abolfazl Mirzadeh, Geita Saadatnia, Majid Golkar, Jalal Babaie, Samira Amiri, Asiyeh Yoosefy

Archives of Clinical Infectious Diseases.2020;[Epub] CrossRef

Rhoptry antigens asToxoplasma gondiivaccine target

Masoud Foroutan, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhosein Dalimi, Ogholniaz Jorjani

Clinical and Experimental Vaccine Research.2019; 8(1): 4. CrossRef

Treatment of toxoplasmosis: Current options and future perspectives

Neda Konstantinovic, Hélène Guegan, Tijana Stäjner, Sorya Belaz, Florence Robert-Gangneux

Food and Waterborne Parasitology.2019; 15: e00036. CrossRef

In silico analysis and expression of a novel chimeric antigen as a vaccine candidate against Toxoplasma gondii

Samira Dodangeh, Mahdi Fasihi-Ramandi, Ahmad Daryani, Reza Valadan, Shahabeddin Sarvi

Evaluation of Anti-Toxoplasma gondii Immune Responses in BALB/c Mice Induced by DNA Vaccines Encoding Surface Antigen 1 (SAG1) and 3 (SAG3)

Molecular Genetics, Microbiology and Virology.2019; 34(1): 59. CrossRef

The course of infection with Toxoplasma gondii RH strain in mice pre-vaccinated with gamma irradiated tachyzoites

Ahmed M. Gomaa, Nora L. El-Tantawy, Aliaa M. Elsawey, Ramy A. Abdelsalam, Manar S. Azab

Experimental Parasitology.2019; 205: 107733. CrossRef

Plant-derived chimeric antibodies inhibit the invasion of human fibroblasts byToxoplasma gondii

Sherene Swee Yin Lim, Kek Heng Chua, Greta Nölke, Holger Spiegel, Wai Leong Goh, Sek Chuen Chow, Boon Pin Kee, Rainer Fischer, Stefan Schillberg, Rofina Yasmin Othman

Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection

Mona Roozbehani, Reza Falak, Mohsen Mohammadi, Andrew Hemphill, Elham Razmjou, Ahmad reza Meamar, Leila Masoori, Majid Khoshmirsafa, Maryam Moradi, Mohammad Javad Gharavi

Synergic in vitro combinations of artemisinin, pyrimethamine and methylene blue against Neospora caninum

Luiz Miguel Pereira, Gabriela de Luca, Nathália de Lima Martins Abichabki, Cássia Mariana Bronzon da Costa, Ana Patrícia Yatsuda

Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice

Mariano S. Picchio, Vanesa R. Sánchez, Nadia Arcon, Ariadna S. Soto, Matías Perrone Sibilia, María de los Angeles Aldirico, Mariela Urrutia, Rosalía Moretta, Ignacio M. Fenoy, Alejandra Goldman, Valentina Martin

Experimental Parasitology.2018; 185: 62. CrossRef

Calcium-dependent protein kinases are potential targets forToxoplasma gondiivaccine

Clinical and Experimental Vaccine Research.2018; 7(1): 24. CrossRef

Recent progress in microneme-based vaccines development againstToxoplasma gondii

Clinical and Experimental Vaccine Research.2018; 7(2): 93. CrossRef

A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006–2016)

Mahbobeh Montazeri, Mehdi Sharif, Shahabeddin Sarvi, Saeed Mehrzadi, Ehsan Ahmadpour, Ahmad Daryani

The genome of the protozoan parasite Cystoisospora suis and a reverse vaccinology approach to identify vaccine candidates

Nicola Palmieri, Aruna Shrestha, Bärbel Ruttkowski, Tomas Beck, Claus Vogl, Fiona Tomley, Damer P. Blake, Anja Joachim

International Journal for Parasitology.2017; 47(4): 189. CrossRef

Immunization with Toxoplasma gondii aspartic protease 3 increases survival time of infected mice

Guanghui Zhao, Xiaojie Song, Xiangnan Kong, Ning Zhang, Shaoling Qu, Wei Zhu, Yanyan Yang, Qian Wang

Vaccination with recombinant adenovirus expressing multi-stage antigens ofToxoplasma gondiiby the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes

Ting Wang, Huiquan Yin, Yan Li, Lingxiao Zhao, Xiahui Sun, Hua Cong

An evaluation of a recombinant multiepitope based antigen for detection of Toxoplasma gondii specific antibodies

Khalid Hajissa, Robaiza Zakaria, Rapeah Suppian, Zeehaida Mohamed

Vaccination against parasites – status quo and the way forward

Immunization of Wistar female rats with 255-Gy-irradiated Toxoplasma gondii: Tissue parasitic load and lactogenic quantification

Lucilene Granuzzio Camossi, Felipe Fornazari, Virgínia Bodelão Richini-Pereira, Rodrigo Costa da Silva, Daniel Fontana Ferreira Cardia, Helio Langoni

Experimental Parasitology.2015; 154: 163. CrossRef

Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection

Vanesa R. Sánchez, Ignacio M. Fenoy, Mariano S. Picchio, Ariadna S. Soto, Nadia Arcon, Alejandra Goldman, Valentina Martin

Seroprevalence of <i>Toxoplasma gondii</i> Among Primary School Children in Shandong Province, China

Ke-Sheng Xin, Hui Liu, Hong-Bing Wang, Zong-Liang Yao

The Korean Journal of Parasitology.2015; 53(4): 489. CrossRef

In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum

Pablo Winzer, Joachim Müller, Adriana Aguado-Martínez, Mahbubur Rahman, Vreni Balmer, Vera Manser, Luis Miguel Ortega-Mora, Kayode K. Ojo, Erkang Fan, Dustin J. Maly, Wesley C. Van Voorhis, Andrew Hemphill

Antimicrobial Agents and Chemotherapy.2015; 59(10): 6361. CrossRef

Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity

Andrew J. Neville, Sydney J. Zach, Xiaofang Wang, Joshua J. Larson, Abigail K. Judge, Lisa A. Davis, Jonathan L. Vennerstrom, Paul H. Davis

Antimicrobial Agents and Chemotherapy.2015; 59(12): 7161. CrossRef